Gordon Keller

USPTO Granted Patents = 20 (Patent Applications = 13)

CIPO Patents = 6 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 15)

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 41(Granted Patents)

Company Filing History:

8 out of 291

University Health Network

patents

8 out of 270

Icahn School of Medicine at Mount Sinai

patents

4 out of 242

Mount Sinai School of Medicine

patents

4. 1 out of 76

Sunnybrook Research Institute

patents

5. 1 out of 165

The Hospital for Sick Children

patents

where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12129490 - Methods for generating hepatocytes and cholangiocytes from pluripotent stem cells (2024-10-29),

2. 11730770 - Methods for making and using sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes (2023-08-22),

3. 11078494 - Vector for targeting the human Rosa26 gene (2021-08-03),

4. 10947506 - Human cardiovascular progenitor cells (2021-03-16),

5. 10736923 - Methods and compositions for generating chondrocyte lineage cells and/or cartilage like tissue (2020-08-11),

6. 10711246 - Methods and compositions for generating epicardium cells (2020-07-14),

7. 10561687 - Methods for making and using sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes (2020-02-18),

8. 10428308 - Mesoderm and definitive endoderm cell populations (2019-10-01),

9. 10392600 - Method of generating human pancreatic cells (2019-08-27),

10. 10077428 - Human cardiovascular progenitor cells (2018-09-18),

11. 9994821 - Methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on SIRPA expression (2018-06-12),

12. 9993504 - Methods and compositions for generating chondrocyte lineage cells and/or cartilage like tissue (2018-06-12),

13. 9834754 - Populations of hematopoietic progenitors and methods of enriching stem cells therefor (2017-12-05),

14. 9745553 - Mesoderm and definitive endoderm cell populations (2017-08-29),

15. 9481896 - Stem cell gene targeting (2016-11-01),

Title: The Innovative Work of Gordon Keller in Stem Cell Research

Introduction: Gordon Keller, a distinguished inventor based in Toronto, CA, has made significant contributions to the field of stem cell research with 20 patents to his name. His groundbreaking work focuses on methods for generating hepatocytes and cholangiocytes from pluripotent stem cells, as well as producing sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes.

Latest Patents: Among his latest patents are methods for generating hepatocytes and cholangiocytes from pluripotent stem cells. These methods involve specifying the extended nodal agonist treated induced endodermal cell population to obtain a cell population comprising hepatocyte and/or cholangiocyte progenitors. Subsequently, the maturation, lineage specification, and expansion of the hepatocyte and/or cholangiocyte progenitors lead to the generation of hepatocyte lineage cells. Additionally, Gordon Keller's patents include methods for making and using sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes.

Career Highlights: Gordon Keller has made remarkable contributions while working at prestigious institutions such as the Icahn School of Medicine at Mount Sinai and the University Health Network. His research has paved the way for advancements in stem cell technologies, particularly in the field of regenerative medicine.

Collaborations: Throughout his career, Gordon Keller has collaborated with esteemed colleagues such as Paul Gadue and Hans Joerg Fehling. Together, they have worked on innovative projects that have furthered our understanding of stem cell differentiation and lineage specification.

Conclusion: Gordon Keller's ingenuity and dedication to stem cell research have positioned him as a leading figure in the field of regenerative medicine. His patented methods for generating hepatocytes, cholangiocytes, and cardiomyocytes from pluripotent stem cells have the potential to revolutionize the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.